Methotrexate Use in Rheumatoid Arthritis-Related Interstitial Lung Disease (RA–ILD): Is It Beneficial?
Mahmoud, B., Abdelkareem, M., Abady, W., Mohamed, H. (2024). Methotrexate Use in Rheumatoid Arthritis-Related Interstitial Lung Disease (RA–ILD): Is It Beneficial?. EKB Journal Management System, 7(2), 694-703. doi: 10.21608/svuijm.2023.199595.1551
Basma Mohamed Awad Mahmoud; Mohamed Ismail Abdelkareem; Wael Abd El-Mohsen Abady; Haggagy Mansour Mohamed. "Methotrexate Use in Rheumatoid Arthritis-Related Interstitial Lung Disease (RA–ILD): Is It Beneficial?". EKB Journal Management System, 7, 2, 2024, 694-703. doi: 10.21608/svuijm.2023.199595.1551
Mahmoud, B., Abdelkareem, M., Abady, W., Mohamed, H. (2024). 'Methotrexate Use in Rheumatoid Arthritis-Related Interstitial Lung Disease (RA–ILD): Is It Beneficial?', EKB Journal Management System, 7(2), pp. 694-703. doi: 10.21608/svuijm.2023.199595.1551
Mahmoud, B., Abdelkareem, M., Abady, W., Mohamed, H. Methotrexate Use in Rheumatoid Arthritis-Related Interstitial Lung Disease (RA–ILD): Is It Beneficial?. EKB Journal Management System, 2024; 7(2): 694-703. doi: 10.21608/svuijm.2023.199595.1551